Opinion: Pharmacists Are Best Suited to Improve Adherence
Learning a patient's specific situation might help overcome adherence barriers.
Duvelisib for Relapsed or Refractory CLL/SLL
Betrixaban for Prophylaxis of Venous Thromboembolism
Betrixaban has been approved by the FDA for patients at risk for thromboembolisms.
2 Commerce Drive Cranbury, NJ 08512